View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 01, 2024
2 min read
Save

Tissue bridges linked with short, long-term benefits in those with spinal cord injury

Tissue bridges linked with short, long-term benefits in those with spinal cord injury

Implementation of tissue bridges measured within the first weeks after spinal cord injury are linked with short-and-long-term clinical improvement, according to research from The Lancet Neurology.

SPONSORED CONTENT
July 01, 2024
5 min read
Save

Protect a physician’s most valuable asset with disability insurance

Protect a physician’s most valuable asset with disability insurance

Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
July 01, 2024
2 min read
Save

Patients with sleep apnea, nighttime hypoxemia face elevated late-onset epilepsy risk

Patients with sleep apnea, nighttime hypoxemia face elevated late-onset epilepsy risk

Nocturnal hypoxemia and sleep apnea raised the risk for late-onset epilepsy even after adjustment for several risk factors and comorbidities, according to results published in Sleep.

SPONSORED CONTENT
June 28, 2024
1 min read
Save

Monoclonal antibody for FSHD improves muscle strength with no serious adverse events

Monoclonal antibody for FSHD improves muscle strength with no serious adverse events

Avidity Biosciences Inc. has announced positive data from the phase 1/2 FORTITUDE clinical trial of a proprietary monoclonal antibody that binds to the transferrin receptor 1 conjugated with a siRNA targeting DUX4 mRNA.

SPONSORED CONTENT
June 28, 2024
2 min read
Save

Narcolepsy tied to elevated risk for heart disease, regardless of sleep apnea status

Narcolepsy tied to elevated risk for heart disease, regardless of sleep apnea status

People with narcolepsy were more likely than propensity score-matched people without narcolepsy to develop heart disease, regardless of sleep apnea status, according to a retrospective cohort study.

SPONSORED CONTENT
June 28, 2024
4 min watch
Save

VIDEO: Antibiotics linked to exacerbation of myasthenia gravis

VIDEO: Antibiotics linked to exacerbation of myasthenia gravis

DENVER — The use of several common antibiotics led to exacerbation of myasthenia gravis in a small cohort of patients, Sanem P. Uysal, MD, said in this Healio video from the American Academy of Neurology annual meeting.

SPONSORED CONTENT
June 27, 2024
1 min read
Save

Results positive in study of antisense oligonucleotide for Huntington’s disease

Results positive in study of antisense oligonucleotide for Huntington’s disease

Wave Life Sciences has announced positive results from its phase 1b/2a clinical trial of WVE-003, a potential disease-modifying therapeutic for Huntington’s disease.

SPONSORED CONTENT
June 27, 2024
2 min read
Save

Patients with migraine report superior outcomes with ubrogepant compared to triptans

Patients with migraine report superior outcomes with ubrogepant compared to triptans

SAN DIEGO — Those with migraine who switched from an oral triptan to ubrogepant reported superior outcomes compared with patients who chose another triptan,, according to data presented at the American Headache Society Annual Scientific Meeting.

SPONSORED CONTENT
June 26, 2024
3 min read
Save

Children with MIS-C or COVID-19 and severe neuro symptoms face long-term impairment risk

Children with MIS-C or COVID-19 and severe neuro symptoms face long-term impairment risk

Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.

SPONSORED CONTENT
June 26, 2024
4 min read
Save

Q&A: SAGE test catches cognitive impairment early in a ‘critical time’

Q&A: SAGE test catches cognitive impairment early in a ‘critical time’

A self-administered assessment tool was effective in identifying cognitive impairment vs. routine care in primary care settings, according to results recently published in Frontiers in Medicine.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails